SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000903423-12-000289
Filing Date
2012-05-16
Accepted
2012-05-16 09:28:54
Documents
1

Document Format Files

Seq Description Document Type Size
1 glaxo-theravance13da2_0515.htm SC 13D/A 112721
  Complete submission text file 0000903423-12-000289.txt   114288
Mailing Address 901 GATEWAY BLVD S. SAN FRANCISCO CA 94080
Business Address 901 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080 6508086000
THERAVANCE INC (Subject) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-80415 | Film No.: 12847398
SIC: 2834 Pharmaceutical Preparations

Mailing Address 980 GREAT WEST ROAD BRENTFORD MIDDLESEX X0 TW8 9GS
Business Address 980 GREAT WEST ROAD BRENTFORD MIDDLESEX X0 TW8 9GS 011442080475000
GLAXOSMITHKLINE PLC (Filed by) CIK: 0001131399 (see all company filings)

IRS No.: 000000000
Type: SC 13D/A
SIC: 2834 Pharmaceutical Preparations